{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:04:37Z","timestamp":1790759077931,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972503"],"award-info":[{"award-number":["81972503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103656"],"award-info":[{"award-number":["82103656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02963-8","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:23:48Z","timestamp":1783315428000},"page":"2693-2707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of TGF-\u03b21\/Smad signaling reverses the dedifferentiated phenotype of thyroid cancer cells in three-dimensional culture"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-8833","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-948X","authenticated-orcid":false,"given":"Zichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"9356","key":"2963_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0140-6736(03)12488-9","volume":"361","author":"SI Sherman","year":"2003","unstructured":"Sherman SI (2003) Thyroid carcinoma. Lancet 361(9356):501\u2013511. https:\/\/doi.org\/10.1016\/s0140-6736(03)12488-9","journal-title":"Lancet"},{"key":"2963_CR2","doi-asserted-by":"publisher","first-page":"204201882110002","DOI":"10.1177\/20420188211000251","volume":"12","author":"LA Stewart","year":"2021","unstructured":"Stewart LA, Kuo JH (2021) Advancements in the treatment of differentiated thyroid cancer. Ther Adv Endocrinol Metab 12:20420188211000251. https:\/\/doi.org\/10.1177\/20420188211000251","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"2963_CR3","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP et al (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91(8):2892\u20132899. https:\/\/doi.org\/10.1210\/jc.2005-2838","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2963_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S2213-8587(13)70215-8","volume":"2","author":"M Schlumberger","year":"2014","unstructured":"Schlumberger M, Brose M, Elisei R, Leboulleux S, Luster M, Pitoia F et al (2014) Definition and management of radioactive iodine-refractory differentiated thyroid cancer. Lancet Diabetes Endocrinol 2(5):356\u2013358. https:\/\/doi.org\/10.1016\/S2213-8587(13)70215-8","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2963_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M (2013) Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 13(3):184\u2013199. https:\/\/doi.org\/10.1038\/nrc3431","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2963_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","volume":"34","author":"J Liu","year":"2019","unstructured":"Liu J, Liu Y, Lin Y, Liang J (2019) Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy. Endocrinol Metab (Seoul) 34(3):215\u2013225. https:\/\/doi.org\/10.3803\/EnM.2019.34.3.215","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2963_CR7","doi-asserted-by":"publisher","first-page":"718578","DOI":"10.3389\/fonc.2021.718578","volume":"11","author":"F Feng","year":"2021","unstructured":"Feng F, Han H, Wu S, Wang H (2021) Crosstalk Between Abnormal TSHR Signaling Activation and PTEN\/PI3K in the Dedifferentiation of Thyroid Cancer Cells. Front Oncol 11:718578. https:\/\/doi.org\/10.3389\/fonc.2021.718578","journal-title":"Front Oncol"},{"issue":"13","key":"2963_CR8","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.7150\/thno.57689","volume":"11","author":"JM Oh","year":"2021","unstructured":"Oh JM, Ahn BC (2021) Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics 11(13):6251\u20136277. https:\/\/doi.org\/10.7150\/thno.57689","journal-title":"Theranostics"},{"issue":"9","key":"2963_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41419-018-0933-y","volume":"9","author":"C Gallo","year":"2018","unstructured":"Gallo C, Fragliasso V, Donati B, Torricelli F, Tameni A, Piana S et al (2018) The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1. Cell Death Dis 9(9):871. https:\/\/doi.org\/10.1038\/s41419-018-0933-y","journal-title":"Cell Death Dis"},{"issue":"7","key":"2963_CR10","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.7150\/jca.64747","volume":"13","author":"C Xiang","year":"2022","unstructured":"Xiang C, Sun WH, Ke Y, Yu X, Wang Y (2022) CDCA8 Contributes to the Development and Progression of Thyroid Cancer through Regulating CDK1. J Cancer 13(7):2322\u20132335. https:\/\/doi.org\/10.7150\/jca.64747","journal-title":"J Cancer"},{"key":"2963_CR11","doi-asserted-by":"publisher","first-page":"1227884","DOI":"10.3389\/fonc.2023.1227884","volume":"13","author":"GM Abd","year":"2023","unstructured":"Abd GM, Laird MC, Ku JC, Li Y (2023) Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. Front Oncol 13:1227884. https:\/\/doi.org\/10.3389\/fonc.2023.1227884","journal-title":"Front Oncol"},{"key":"2963_CR12","doi-asserted-by":"publisher","first-page":"154495","DOI":"10.1016\/j.prp.2023.154495","volume":"246","author":"L Zhang","year":"2023","unstructured":"Zhang L, Xu S, Cheng X, Wu J, Wang Y, Gao W et al (2023) Inflammatory tumor microenvironment of thyroid cancer promotes cellular dedifferentiation and silencing of iodide-handling genes expression. Pathol Res Pract 246:154495. https:\/\/doi.org\/10.1016\/j.prp.2023.154495","journal-title":"Pathol Res Pract"},{"issue":"8","key":"2963_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2174\/138920211798120808","volume":"12","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Fallahi P, Ferrari SM, Ruffilli I, Santini F, Minuto M et al (2011) New targeted therapies for thyroid cancer. Curr Genomics 12(8):626\u2013631. https:\/\/doi.org\/10.2174\/138920211798120808","journal-title":"Curr Genomics"},{"issue":"8","key":"2963_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.2967\/jnumed.125.270055","volume":"66","author":"J von Hinten","year":"2025","unstructured":"von Hinten J, Viering O, Bundschuh RA, Cagliyan F, Wengenmair H, Pfob CH et al (2025) Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer. J Nucl Med 66(8):1192\u20131196. https:\/\/doi.org\/10.2967\/jnumed.125.270055","journal-title":"J Nucl Med"},{"issue":"20","key":"2963_CR15","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1080\/14796694.2025.2531575","volume":"21","author":"T Gauduchon","year":"2025","unstructured":"Gauduchon T, Varnier R, Cassier PA (2025) Selpercatinib in the treatment of thyroid cancer. Future Oncol 21(20):2585\u20132592. https:\/\/doi.org\/10.1080\/14796694.2025.2531575","journal-title":"Future Oncol"},{"issue":"3","key":"2963_CR16","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1097\/RLU.0000000000004475","volume":"48","author":"HP Chan","year":"2023","unstructured":"Chan HP, Chen IF, Tsai FR, Kao CH, Shen DH (2023) Reversing Flip-Flop Phenomenon of 131 I and Glucose Avidity in RET-Fusion Positive Radioiodine-Refractory Thyroid Cancer Lesions After Treatment of Pralsetinib. Clin Nucl Med 48(3):e147\u2013e148. https:\/\/doi.org\/10.1097\/RLU.0000000000004475","journal-title":"Clin Nucl Med"},{"issue":"4","key":"2963_CR17","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5114\/aoms.2016.63743","volume":"14","author":"M Kapalczynska","year":"2018","unstructured":"Kapalczynska M, Kolenda T, Przybyla W, Zajaczkowska M, Teresiak A, Filas V et al (2018) 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch Med Sci 14(4):910\u2013919. https:\/\/doi.org\/10.5114\/aoms.2016.63743","journal-title":"Arch Med Sci"},{"issue":"4","key":"2963_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","volume":"12","author":"R Edmondson","year":"2014","unstructured":"Edmondson R, Broglie JJ, Adcock AF, Yang L (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12(4):207\u2013218. https:\/\/doi.org\/10.1089\/adt.2014.573","journal-title":"Assay Drug Dev Technol"},{"issue":"5","key":"2963_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/labinvest.2013.41","volume":"93","author":"JM Lee","year":"2013","unstructured":"Lee JM, Mhawech-Fauceglia P, Lee N, Parsanian LC, Lin YG, Gayther SA et al (2013) A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest 93(5):528\u2013542. https:\/\/doi.org\/10.1038\/labinvest.2013.41","journal-title":"Lab Invest"},{"issue":"1","key":"2963_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12967-022-03848-z","volume":"21","author":"D Chen","year":"2023","unstructured":"Chen D, Su X, Zhu L, Jia H, Han B, Chen H et al (2023) Papillary thyroid cancer organoids harboring BRAF(V600E) mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies. J Transl Med 21(1):9. https:\/\/doi.org\/10.1186\/s12967-022-03848-z","journal-title":"J Transl Med"},{"issue":"3","key":"2963_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41388-023-02889-y","volume":"43","author":"H Lasolle","year":"2024","unstructured":"Lasolle H, Schiavo A, Tourneur A, Gillotay P, de Faria da Fonseca B, Ceolin L et al (2024) Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids. Oncogene 43(3):155\u2013170. https:\/\/doi.org\/10.1038\/s41388-023-02889-y","journal-title":"Oncogene"},{"issue":"2","key":"2963_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1530\/ERC-19-0374","volume":"27","author":"MA Lee","year":"2020","unstructured":"Lee MA, Bergdorf KN, Phifer CJ, Jones CY, Byon SY, Sawyer LM et al (2020) Novel three-dimensional cultures provide insights into thyroid cancer behavior. Endocr Relat Cancer 27(2):111\u2013121. https:\/\/doi.org\/10.1530\/ERC-19-0374","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2963_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald LB, Bellet D, Dangles-Marie V (2015) Spherical cancer models in tumor biology. Neoplasia 17(1):1\u201315. https:\/\/doi.org\/10.1016\/j.neo.2014.12.004","journal-title":"Neoplasia"},{"issue":"6","key":"2963_CR24","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1002\/ptr.7065","volume":"35","author":"L Zhang","year":"2021","unstructured":"Zhang L, Xu S, Cheng X, Zheng J, Wang Y, Wu J et al (2021) Diallyl trisulphide, a H(2) S donor, compromises the stem cell phenotype and restores thyroid-specific gene expression in anaplastic thyroid carcinoma cells by targeting AKT-SOX2 axis. Phytother Res 35(6):3428\u20133443. https:\/\/doi.org\/10.1002\/ptr.7065","journal-title":"Phytother Res"},{"issue":"3","key":"2963_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1023\/b:neon.0000024220.07063.70","volume":"67","author":"D Del Duca","year":"2004","unstructured":"Del Duca D, Werbowetski T, Del Maestro RF (2004) Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 67(3):295\u2013303. https:\/\/doi.org\/10.1023\/b:neon.0000024220.07063.70","journal-title":"J Neurooncol"},{"issue":"2","key":"2963_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.22074\/cellj.2016.4184","volume":"19","author":"H Azizi","year":"2017","unstructured":"Azizi H, Skutella T, Shahverdi A (2017) Generation of Mouse Spermatogonial Stem-Cell-Colonies in A Non-Adherent Culture. Cell J 19(2):238\u2013249. https:\/\/doi.org\/10.22074\/cellj.2016.4184","journal-title":"Cell J"},{"issue":"9","key":"2963_CR27","first-page":"1808","volume":"58","author":"CD Lu","year":"1998","unstructured":"Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58(9):1808\u20131812","journal-title":"Cancer Res"},{"issue":"12","key":"2963_CR28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1631\/jzus.B1600542","volume":"18","author":"XH Guo","year":"2017","unstructured":"Guo XH, Ni J, Xue JL, Wang X (2017) Phyllanthus emblica Linn. fruit extract potentiates the anticancer efficacy of mitomycin C and cisplatin and reduces their genotoxicity to normal cells in vitro. J Zhejiang Univ Sci B 18(12):1031\u20131045. https:\/\/doi.org\/10.1631\/jzus.B1600542","journal-title":"J Zhejiang Univ Sci B"},{"issue":"11","key":"2963_CR29","doi-asserted-by":"publisher","first-page":"e169653","DOI":"10.1172\/JCI169653","volume":"133","author":"L Lu","year":"2023","unstructured":"Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M et al (2023) Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest 133(11):e169653. https:\/\/doi.org\/10.1172\/JCI169653","journal-title":"J Clin Invest"},{"key":"2963_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1741-7007-10-29","volume":"10","author":"M Vinci","year":"2012","unstructured":"Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W et al (2012) Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10:29. https:\/\/doi.org\/10.1186\/1741-7007-10-29","journal-title":"BMC Biol"},{"issue":"8","key":"2963_CR31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neo.2019.06.005","volume":"21","author":"MR Ward Rashidi","year":"2019","unstructured":"Ward Rashidi MR, Mehta P, Bregenzer M, Raghavan S, Fleck EM, Horst EN et al (2019) Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance. Neoplasia 21(8):822\u2013836. https:\/\/doi.org\/10.1016\/j.neo.2019.06.005","journal-title":"Neoplasia"},{"key":"2963_CR32","doi-asserted-by":"publisher","first-page":"821958","DOI":"10.3389\/fonc.2022.821958","volume":"12","author":"Y Cui","year":"2022","unstructured":"Cui Y, Liu Y, Mu L, Li Y, Wu G (2022) Transcriptional Expressions of ALDH1A1\/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients. Front Oncol 12:821958. https:\/\/doi.org\/10.3389\/fonc.2022.821958","journal-title":"Front Oncol"},{"issue":"12","key":"2963_CR33","doi-asserted-by":"publisher","first-page":"e12102","DOI":"10.7759\/cureus.12102","volume":"12","author":"W Gomaa","year":"2020","unstructured":"Gomaa W, Marouf A, Alamoudi A, Al-Maghrabi J (2020) SOX2 Is a Potential Novel Marker of Undifferentiated Thyroid Carcinomas. Cureus 12(12):e12102. https:\/\/doi.org\/10.7759\/cureus.12102","journal-title":"Cureus"},{"issue":"4","key":"2963_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.23736\/S1824-4785.18.03088-1","volume":"64","author":"YJ Hsieh","year":"2020","unstructured":"Hsieh YJ, Lu TY, Ke CC, Lin YS, Tai HT, Liu SI et al (2020) Correlation of 18F-FDG uptake and thyroid cancer stem cells. Q J Nucl Med Mol Imaging 64(4):393\u2013399. https:\/\/doi.org\/10.23736\/S1824-4785.18.03088-1","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7941","key":"2963_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41586-022-05530-2","volume":"612","author":"S Ravera","year":"2022","unstructured":"Ravera S, Nicola JP, Salazar-De Simone G, Sigworth FJ, Karakas E, Amzel LM et al (2022) Structural insights into the mechanism of the sodium\/iodide symporter. Nature 612(7941):795\u2013801. https:\/\/doi.org\/10.1038\/s41586-022-05530-2","journal-title":"Nature"},{"issue":"11","key":"2963_CR36","doi-asserted-by":"publisher","first-page":"e0142984","DOI":"10.1371\/journal.pone.0142984","volume":"10","author":"T Chung","year":"2015","unstructured":"Chung T, Youn H, Yeom CJ, Kang KW, Chung JK (2015) Glycosylation of Sodium\/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake. PLoS ONE 10(11):e0142984. https:\/\/doi.org\/10.1371\/journal.pone.0142984","journal-title":"PLoS ONE"},{"issue":"4","key":"2963_CR37","doi-asserted-by":"publisher","first-page":"e4321","DOI":"10.21769\/BioProtoc.4321","volume":"12","author":"Z Javed","year":"2022","unstructured":"Javed Z, Worley BL, Stump C, Shimko SS, Crawford LC, Mythreye K et al (2022) Optimization of Extracellular Flux Assay to Measure Respiration of Anchorage-independent Tumor Cell Spheroids. Bio Protoc 12(4):e4321. https:\/\/doi.org\/10.21769\/BioProtoc.4321","journal-title":"Bio Protoc"},{"issue":"22","key":"2963_CR38","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.3390\/cells11223559","volume":"11","author":"JM Oh","year":"2022","unstructured":"Oh JM, Gangadaran P, Rajendran RL, Hong CM, Lee J, Ahn BC (2022) Different Expression of Thyroid-Specific Proteins in Thyroid Cancer Cells between 2-Dimensional (2D) and 3-Dimensional (3D) Culture Environment. Cells 11(22):3559. https:\/\/doi.org\/10.3390\/cells11223559","journal-title":"Cells"},{"key":"2963_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fendo.2014.00114","volume":"5","author":"R Ma","year":"2014","unstructured":"Ma R, Bonnefond S, Morshed SA, Latif R, Davies TF (2014) Stemness is Derived from Thyroid Cancer Cells. Front Endocrinol (Lausanne) 5:114. https:\/\/doi.org\/10.3389\/fendo.2014.00114","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2963_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid Cancer: A Review. JAMA 331(5):425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"JAMA"},{"issue":"2","key":"2963_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/PAS.0000000000002153","volume":"48","author":"WS Mneimneh","year":"2024","unstructured":"Mneimneh WS, Asa SL (2024) Divergent Lineage Markers in Anaplastic Thyroid Carcinoma. Am J Surg Pathol 48(2):230\u2013237. https:\/\/doi.org\/10.1097\/PAS.0000000000002153","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2963_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41418-019-0367-9","volume":"27","author":"C Jiao","year":"2020","unstructured":"Jiao C, Li L, Zhang P, Zhang L, Li K, Fang R et al (2020) REGgamma ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-beta pathway. Cell Death Differ 27(2):497\u2013508. https:\/\/doi.org\/10.1038\/s41418-019-0367-9","journal-title":"Cell Death Differ"},{"issue":"42","key":"2963_CR43","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1038\/onc.2016.89","volume":"35","author":"J Wu","year":"2016","unstructured":"Wu J, Lu M, Li Y, Shang YK, Wang SJ, Meng Y et al (2016) Regulation of a TGF-beta1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells. Oncogene 35(42):5468\u20135479. https:\/\/doi.org\/10.1038\/onc.2016.89","journal-title":"Oncogene"},{"issue":"3","key":"2963_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676\u2013690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"Cell"},{"key":"2963_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.04.001","volume":"71\u201372","author":"M Turati","year":"2023","unstructured":"Turati M, Mousset A, Issa N, Turtoi A, Ronca R (2023) TGF-beta mediated drug resistance in solid cancer. Cytokine Growth Factor Rev 71\u201372:54\u201365. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.04.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"2963_CR46","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fendo.2020.00566","volume":"11","author":"V Veschi","year":"2020","unstructured":"Veschi V, Verona F, Lo Iacono M, D\u2019Accardo C, Porcelli G, Turdo A et al (2020) Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis. Front Endocrinol (Lausanne) 11:566. https:\/\/doi.org\/10.3389\/fendo.2020.00566","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2963_CR47","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1089\/thy.2007.0303","volume":"19","author":"MA Pisarev","year":"2009","unstructured":"Pisarev MA, Thomasz L, Juvenal GJ (2009) Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid 19(8):881\u2013892. https:\/\/doi.org\/10.1089\/thy.2007.0303","journal-title":"Thyroid"},{"issue":"49","key":"2963_CR48","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1038\/sj.onc.1207029","volume":"22","author":"SB Bravo","year":"2003","unstructured":"Bravo SB, Pampin S, Cameselle-Teijeiro J, Carneiro C, Dominguez F, Barreiro F et al (2003) TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation. Oncogene 22(49):7819\u20137830. https:\/\/doi.org\/10.1038\/sj.onc.1207029","journal-title":"Oncogene"},{"issue":"1","key":"2963_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13044-025-00243-w","volume":"18","author":"J Xiang","year":"2025","unstructured":"Xiang J, Lv N, Yin S, Zhao T, Liu F, Cheng L et al (2025) TGF-beta induces EMT in thyroid cancer cells by regulating transcription factors. Thyroid Res 18(1):25. https:\/\/doi.org\/10.1186\/s13044-025-00243-w","journal-title":"Thyroid Res"},{"issue":"2","key":"2963_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12020-022-02990-4","volume":"76","author":"NM Latar","year":"2022","unstructured":"Latar NM, Mahkamova K, Elson J, Karnik I, Sutherland R, Aspinall S et al (2022) Impact of transforming growth factor beta 1 on normal and thyroid cancer side population cells. Endocrine 76(2):359\u2013368. https:\/\/doi.org\/10.1007\/s12020-022-02990-4","journal-title":"Endocrine"},{"issue":"1","key":"2963_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13277-013-1053-z","volume":"35","author":"J Zhang","year":"2014","unstructured":"Zhang J, Wang Y, Li D, Jing S (2014) Notch and TGF-beta\/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma. Tumour Biol 35(1):379\u2013385. https:\/\/doi.org\/10.1007\/s13277-013-1053-z","journal-title":"Tumour Biol"},{"issue":"5","key":"2963_CR52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12032-025-02667-8","volume":"42","author":"KC Himani","year":"2025","unstructured":"Himani KC, Kumar R, Mishra R, Singh G (2025) Targeting TGF-beta: a promising strategy for cancer therapy. Med Oncol 42(5):142. https:\/\/doi.org\/10.1007\/s12032-025-02667-8","journal-title":"Med Oncol"},{"issue":"1","key":"2963_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/cac2.12244","volume":"42","author":"B Cheng","year":"2022","unstructured":"Cheng B, Ding K, Chen P, Ji J, Luo T, Guo X et al (2022) Anti-PD-L1\/TGF-betaR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1\/PD-L1 inhibitors in lung cancer. Cancer Commun (Lond) 42(1):17\u201336. https:\/\/doi.org\/10.1002\/cac2.12244","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"2963_CR54","doi-asserted-by":"publisher","first-page":"e007353","DOI":"10.1136\/jitc-2023-007353","volume":"11","author":"TM Bauer","year":"2023","unstructured":"Bauer TM, Santoro A, Lin CC, Garrido-Laguna I, Joerger M, Greil R et al (2023) Phase I\/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-beta monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors. J Immunother Cancer 11(11):e007353. https:\/\/doi.org\/10.1136\/jitc-2023-007353","journal-title":"J Immunother Cancer"},{"issue":"12","key":"2963_CR55","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1016\/j.ymthe.2025.10.033","volume":"33","author":"Y Han","year":"2025","unstructured":"Han Y, Koehler VF, Nagarajah J, Schmohl KA, Stauss C, Schwenk N et al (2025) TGF-beta1-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCs. Mol Ther 33(12):6130\u20136145. https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.033","journal-title":"Mol Ther"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02963-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02963-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02963-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:51Z","timestamp":1790757231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02963-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2963"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02963-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}